Evolution of covered stents in the contemporary era: Clinical application, materials and manufacturing strategies using nanotechnology

Biotechnology Advances

Volumn 31, Issue 5, 2013, Pages 524-542

  Farhatnia, Yasmin ^a   Tan, Aaron ^a,b   Motiwala, Aamir ^a   Cousins, Brian G ^a   Seifalian, Alexander M ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Covered stent; Nanocomposite; Nitinol; Percutaneous transluminal angioplasty; Polymer; POSS PCU; PTFE

Indexed keywords

COVERED STENT; INTERVENTIONAL CARDIOLOGY; MANUFACTURING PROCESS; MANUFACTURING STRATEGY; NITINOL; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTIES; POSS-PCU; VASCULAR COMPLICATIONS;

NANOCOMPOSITES; NANOTECHNOLOGY; POLYMERS; POLYTETRAFLUOROETHYLENES;

STENTS;

ALLOY; NANOCOMPOSITE; NITINOL; POLYMER;

BIOTECHNOLOGY; CARDIOLOGY; COMPOSITE; FUTURE PROSPECT; MANUFACTURING; NANOTECHNOLOGY; PATHOLOGY; POLYMER;

CHEMISTRY; METHODOLOGY; NANOTECHNOLOGY; PROSTHESIS; REVIEW; STENT;

ALLOYS; NANOCOMPOSITES; NANOTECHNOLOGY; POLYMERS; PROSTHESIS DESIGN; STENTS;

EID: 84879411418     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.12.010     Document Type: Review

References (178)

1. Abbott JoStent graftmaster coronary stent graft system [Ref Type: Electronic Citation]. http://www.abbottvascular.com/int/jostent-graftmaster-coronary-stent-graft-system.html.
2. Abbott JoStent peripheral stent graft [Ref Type: Electronic Citation]. http://www.abbottvascular.com/int/jostent-stent-graft.html.
3. Acharya G., Park K. Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev 2006, 58:387-401.
4. Amiji M.M. Permeability and blood compatibility properties of chitosan-poly(ethylene oxide) blend membranes for haemodialysis. Biomaterials 1995, 16:593-599.
5. Archondakis E., Pero G., Valvassori L., Boccardi E., Scialfa G. Angiographic follow-up of traumatic carotid cavernous fistulas treated with endovascular stent graft placement. AJNR Am J Neuroradiol 2007, 28:342-347.
6. Assali A., Raz Y., Vaknin-Assa H., Ben-Dor I., Brosh D., Teplitsky I., et al. Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions. EuroIntervention 2008, 4:108-114.
7. Atrium Advanta Atrium Advanta V12 brochure [Ref Type: Electronic Citation]. http://www.atriummed.com/en/interventional/Documents/V12%20Vascular%200010F.pdf.
8. Atrium Advanta Atrium Advanta V12 technical data [Ref Type: Electronic Citation]. http://www.atriummed.com/en/interventional/Documents/V12Datasheet0020C.pdf.
9. Atrium Advanta Atrium Advanta V12 instructions for use [Ref Type: Electronic Citation]. http://www.atriummed.com/en/interventional/Documents/V12%20IFU.pdf.
10. Atrium iCAST Atrium iCAST brochure [Ref Type: Electronic Citation]. http://www.atriummed.com/en/interventional/Documents/iCAST%20Brochure%20003603G.pdf.
11. Atrium iCAST Atrium iCAST technical data [Ref Type: Electronic Citation]. http://www.atriummed.com/en/interventional/Documents/iCAST%20Datasheet%20003620D.pdf.
12. Atrium iCAST Atrium iCAST instructions for use [Ref Type: Electronic Citation]. http://www.atriummed.com/en/interventional/Documents/iCAST%20IFU.pdf.
13. Bagnaninchi P.O., Dikeakos M., Veres T., Tabrizian M. Towards on-line monitoring of cell growth in microporous scaffolds: utilization and interpretation of complex permittivity measurements. Biotechnol Bioeng 2003, 84:343-350.
14. Bajaj S., Parikh R., Hamdan A., Bikkina M. Covered-stent treatment of coronary aneurysm after drug-eluting stent placement: case report and literature review. Tex Heart Inst J 2010, 37:449-454.
15. BARD peripheral vascular fluency&vascular stent graft [Ref Type: Electronic Citation]. http://www.bardpv.com/_europe/product.php?p=22.
16. BARD peripheral vascular fluency&vascular stent graft instructions for use [Ref Type: Electronic Citation]. http://www.bardpv.com/pdfs/B05663_Version_3.pdf.
17. Bell B., Bett N., Walters D.L. Fistula from aneurysmal saphenous vein graft to right atrium treated with covered stents. Heart Lung Circ 2010, 19:465-469.
18. Ben-Dor I., Lager R., Waksman R., Pichard A.D., Gallino R. Giant saphenous vein graft aneurysm treated with covered stent. Cardiovasc Revasc Med 2011.
19. Berger H.L. Using ultrasonic spray nozzles to coat drug-eluting stents. Med Device Technol 2006, 17:44-49.
20. Bonello L., Com O., Gaubert J.Y., Sbraggia P., Paganelli F. Covered stent for closure of symptomatic plexus-like coronary fistula. Int J Cardiol 2006, 109:408-410.
21. Borrajo J.P., Serra J., Gonzalez P., Leon B., Munoz F.M., Lopez M. In vivo evaluation of titanium implants coated with bioactive glass by pulsed laser deposition. J Mater Sci Mater Med 2007, 18:2371-2376.
22. Boston Scientific Platinum chromium stent series [Ref Type: Electronic Citation]. http://www.bostonscientific.com/element-stent/strength-flexibility.html?
23. Briguori C., Nishida T., Anzuini A., di M.C., Grube E., Colombo A. Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures. Circulation 2000, 102:3028-3031.
24. Briguori C., Sarais C., Sivieri G., Takagi T., di M.C., Colombo A. Polytetrafluoroethylene-covered stent and coronary artery aneurysms. Catheter Cardiovasc Interv 2002, 55:326-330.
25. Brito L.A., Chandrasekhar S., Little S.R., Amiji M.M. Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis. Biomed Eng Online 2010, 9:56.
26. Bruckheimer E., Dagan T., Amir G., Birk E. Covered Cheatham-platinum stents for serial dilation of severe native aortic coarctation. Catheter Cardiovasc Interv 2009, 74:117-123.
27. Bruckheimer E., Birk E., Santiago R., Dagan T., Esteves C., Pedra C.A. Coarctation of the aorta treated with the Advanta V12 large diameter stent: acute results. Catheter Cardiovasc Interv 2010, 75:402-406.
28. Butera G., Piazza L., Chessa M., Abella R., Bussadori C., Negura D., et al. Covered stents in patients with congenital heart defects. Catheter Cardiovasc Interv 2006, 67:466-472.
29. Butera G., Gaio G., Carminati M. Redilation of e-PTFE covered CP stents. Catheter Cardiovasc Interv 2008, 72:273-277.
30. Butera G., Heles M., MacDonald S.T., Carminati M. Aortic coarctation complicated by wall aneurysm: the role of covered stents. Catheter Cardiovasc Interv 2010, 78:926-932.
31. Chaloupka K., Motwani M., Seifalian A.M. Development of a new lacrimal drainage conduit using POSS nanocomposite. Biotechnol Appl Biochem 2011, 58:363-370.
32. Cloft H.J., Kallmes D.F., Lin H.B., Li S.T., Marx W.F., Hudson S.B., et al. Bovine type I collagen as an endovascular stent-graft material: biocompatibility study in rabbits. Radiology 2000, 214:557-562.
33. Colombo A., Almagor Y., Gaspar J., Vonderwalde C. The pericardium covered stent (PCS). EuroIntervention 2009, 5:394-399.
34. Costa J.R., Abizaid A., Feres F., Costa R., Staico R., Siqueira D., et al. One-year results of the INSPIRE trial with the novel MGuard stent: serial analysis with QCA and IVUS. Catheter Cardiovasc Interv 2011, 78:1095-1100.
35. Cowley C.G., Orsmond G.S., Feola P., McQuillan L., Shaddy R.E. Long-term, randomized comparison of balloon angioplasty and surgery for native coarctation of the aorta in childhood. Circulation 2005, 111:3453-3456.
36. Criado F. Editor's corner: Going below the knee: not without challenges. Vasc Dis Manag 2008, 5.
37. Dixon S.R., Skelding K.A., Frumin H.I., O'Neill W.W. Occlusion of a saphenous vein graft aneurysm with a vein-covered stent. J Interv Cardiol 2002, 15:201-204.
38. Dziewierz A., Dudek D. Advantages of MGuard coronary stent system. Minerva Cardioangiol 2012, 60:33-40.
39. Esquivel C.O., Bjorck C.G., Bergentz S.E., Bergqvist D., Larsson R., Carson S.N., et al. Reduced thrombogenic characteristics of expanded polytetrafluoroethylene and polyurethane arterial grafts after heparin bonding. Surgery 1984, 95:102-107.
40. Fanelli F., Dake M.D. Standard of practice for the endovascular treatment of thoracic aortic aneurysms and type B dissections. Cardiovasc Intervent Radiol 2009, 32:849-860.
41. Forbes T.J., Garekar S., Amin Z., Zahn E.M., Nykanen D., Moore P., et al. Procedural results and acute complications in stenting native and recurrent coarctation of the aorta in patients over 4years of age: a multi-institutional study. Catheter Cardiovasc Interv 2007, 70:276-285.
42. Garg S., Serruys P.W. Coronary stents: looking forward. J Am Coll Cardiol 2010, 56:S43-S78.
43. Ghanbari H., Marashi S.M., Rafiei Y., Chaloupka K., Seifalian A.M. Biomedical application of polyhedral oligomeric silsesquioxane nanoparticles application of polyhedral oligomeric silsesquioxane nanoparticles 2011, 363-399.
44. Golden A.B., Hellenbrand W.E. Coarctation of the aorta: stenting in children and adults. Catheter Cardiovasc Interv 2007, 69:289-299.
45. Goodwin S.C., Yoon H.C., Wong G.C., Bonilla S.M., Vedantham S., Arora L.C. Percutaneous delivery of a heparin-impregnated collagen stent-graft in a porcine model of atherosclerotic disease. Invest Radiol 2000, 35:420-425.
46. Gorbet M.B., Sefton M.V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004, 25:5681-5703.
47. Gordon B.M., Fishbein M.C., Levi D.S. Polytetrafluoroethylene-covered stents in the venous and arterial system: angiographic and pathologic findings in a swine model. Cardiovasc Pathol 2008, 17:206-211.
48. Gordon B.M., Fishbein M.C., Levi D.S. Serial late dilatations of expanded polytetrafluoroethylene-covered stents in porcine aorta. Catheter Cardiovasc Interv 2008, 72:400-407.
49. GORE GORE Viabahn endoprosthesis [Ref Type: Electronic Citation]. http://www.goremedical.com/eu/viabahneu/.
50. GORE GORE Viabahn endoprosthesis instructions for use [Ref Type: Electronic Citation]. http://www.goremedical.com/eu/viabahneu/instructions/.
51. Gunning M.G., Williams I.L., Jewitt D.E., Shah A.M., Wainwright R.J., Thomas M.R. Coronary artery perforation during percutaneous intervention: incidence and outcome. Heart 2002, 88:495-498.
52. Gurbel P.A., Criado F.J., Curnutte E.A., Patten P., Secada-Lovio J. Percutaneous revascularization of an extensively diseased saphenous vein bypass graft with a saphenous vein-covered Palmaz stent. Cathet Cardiovasc Diagn 1997, 40:75-78.
53. Hamid H., Coltart J. Miracle stents'-a future without restenosis. Mcgill J Med 2007, 10(2):105-111.
54. Hanefeld P., Westedt U., Wombacher R., Kissel T., Schaper A., Wendorff J.H., et al. Coating of poly(p-xylylene) by PLA-PEO-PLA triblock copolymers with excellent polymer-polymer adhesion for stent applications. Biomacromolecules 2006, 7:2086-2090.
55. Hans F.J., Moller-Hartmann W., Brunn A., Schmitz-Rode T., Thron A., Krings T. Treatment of wide-necked aneurysms with balloon-expandable polyurethane-covered stentgrafts: experience in an animal model. Acta Neurochir (Wien) 2005, 147:871-876.
56. Hayat S.A., Ghani S., More R.S. Treatment of ruptured coronary aneurysm with a novel covered stent. Catheter Cardiovasc Interv 2009, 74:367-370.
57. He L., Xue R., Yang D., Liu Y., Song R. Effects of blending chitosan with PEG on surface morphology, crystallization and thermal properties. Chin J Polym Sci 2009, 27:501-510.
58. Holmes D.R., Camrud A.R., Jorgenson M.A., Edwards W.D., Schwartz R.S. Polymeric stenting in the porcine coronary artery model: differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents. J Am Coll Cardiol 1994, 24:525-531.
59. Horita N., Tomita H., Takamuro M., Fuse S., Tsutsumi H. Development of a reexpandable covered stent for children. Catheter Cardiovasc Interv 2006, 68:727-734.
60. Hornung T.S., Benson L.N., McLaughlin P.R. Interventions for aortic coarctation. Cardiol Rev 2002, 10:139-148.
61. Hu B., Wang S.S., Li J., Zeng X.X., Huang Q.R. Assembly of bioactive peptide-chitosan nanocomplexes. J Phys Chem B 2011, 115:7515-7523.
62. Inoue T., Node K. Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 2009, 73:615-621.
63. Ionita C.N., Dohatcu A., Sinelnikov A., Sherman J., Keleshis C., Paciorek A.M., et al. Angiographic analysis of animal model aneurysms treated with novel polyurethane asymmetric vascular stent (P-AVS): feasibility study. Proc Soc Photo Opt Instrum Eng 2009, 7262. [72621H1-72621H10].
64. ITGI Medical Over and under covered stent [Ref Type: Electronic Citation]. http://www.itgimedical.com/eng/cardiology/cardiology.asp.
65. Jaffe R., Deykin D. Evidence for a structural requirement for the aggregation of platelets by collagen. J Clin Invest 1974, 53:875-883.
66. Jamshidi P., Mahmoody K., Erne P. Covered stents: a review. Int J Cardiol 2008, 130:310-318.
67. Jason David Weaver. Development of a polyvinyl alcohol cryogel covered stent. 2010. Ref Type: Thesis/Dissertation.
68. Jiang T., Wang G., Qiu J., Luo L., Zhang G. Heparinized poly(vinyl alcohol)-small intestinal submucosa composite membrane for coronary covered stents. Biomed Mater 2009, 4:025012.
69. Jungebluth P., Alici E., Baiguera S., Le B.K., Blomberg P., Bozoky B., et al. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet 2011, 378:1997-2004.
70. Kabir A.M., Selvarajah A., Seifalian A.M. How safe and how good are drug-eluting stents?. Future Cardiol 2011, 7:251-270.
71. Kallinteri P., Antimisiaris S.G., Karnabatidis D., Kalogeropoulou C., Tsota I., Siablis D. Dexamethasone incorporating liposomes: an in vitro study of their applicability as a slow releasing delivery system of dexamethasone from covered metallic stents. Biomaterials 2002, 23:4819-4826.
72. Karnabatidis D., Katsanos K., Siablis D. Infrapopliteal stents: overview and unresolved issues. J Endovasc Ther 2009, 16(Suppl. 1):I153-I162.
73. Kenny D., Margey R., Turner M.S., Tometzki A.J., Walsh K.P., Martin R.P. Self-expanding and balloon expandable covered stents in the treatment of aortic coarctation with or without aneurysm formation. Catheter Cardiovasc Interv 2008, 72:65-71.
74. Kiernan T.J., Yan B.P., Ruggiero N., Eisenberg J.D., Bernal J., Cubeddu R.J., et al. Coronary artery perforations in the contemporary interventional era. J Interv Cardiol 2009, 22:350-353.
75. Kipshidze N., Ferguson J.J., Keelan M.H., Sahota H., Komorowski R., Shankar L.R., et al. Endoluminal reconstruction of the arterial wall with endothelial cell/glue matrix reduces restenosis in an atherosclerotic rabbit. J Am Coll Cardiol 2000, 36:1396-1403.
76. Koromila G., Michanetzis G.P., Missirlis Y.F., Antimisiaris S.G. Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: effect on haemocompatibility. Biomaterials 2006, 27:2525-2533.
77. Kuraishi K., Iwata H., Nakano S., Kubota S., Tonami H., Toda M., et al. Development of nanofiber-covered stents using electrospinning: in vitro and acute phase in vivo experiments. J Biomed Mater Res B Appl Biomater 2009, 88:230-239.
78. Kyoto Medical Planning Igaki-Tamai Stent [10-6-2011. Ref Type: Electronic Citation]. http://www.kyoto-mp.co.jp/news/080125_en.html.
79. Laarman G.J., Kiemeneij F., Mueller R., Guagliumi G., Cobaugh M., Serruys P.W. Feasibility, safety, and preliminary efficacy of a novel ePTFE-covered self-expanding stent in saphenous vein graft lesions: the Symbiot II trial. Catheter Cardiovasc Interv 2005, 64:361-368.
80. Lanzer P., Topol E.J. Vascular Extracellular MatrixPan vascular medicine: integrated clinical management 2001, Springer.
81. Lee M.S., Yang T., Kandzari D.E., Tobis J.M., Liao H., Mahmud E. Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention. Am J Cardiol 2010, 105:1076-1082.
82. Li M.H., Leng B., Li Y.D., Tan H.Q., Wang W., Song D.L., et al. Comparative study of covered stent with coil embolization in the treatment of cranial internal carotid artery aneurysm: a nonrandomized prospective trial. Eur Radiol 2010, 20:2732-2739.
83. Ly H., Awaida J.P., Lesperance J., Bilodeau L. Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations. Am J Cardiol 2005, 95:244-246.
84. Mahmud E., Cavendish J.J., Salami A. Current treatment of peripheral arterial disease: role of percutaneous interventional therapies. J Am Coll Cardiol 2007, 50:473-490.
85. Mani G., Feldman M.D., Patel D., Agrawal C.M. Coronary stents: a materials perspective. Biomaterials 2007, 28:1689-1710.
86. Marty B., Leu A.J., Mucciolo A., von Segesser L.K. Biologic fixation of polyester- versus polyurethane-covered stents in a porcine model. J Vasc Interv Radiol 2002, 13:601-607.
87. McKenna C.J., Camrud A.R., Sangiorgi G., Kwon H.M., Edwards W.D., Holmes D.R., et al. Fibrin-film stenting in a porcine coronary injury model: efficacy and safety compared with uncoated stents. J Am Coll Cardiol 1998, 31:1434-1438.
88. Michael The MGuard™: coronary stent and embolic protection device [Ref Type: Electronic Citation]. http://www.medgadget.com/2007/10/the_mguard_a_coronary_stent_and_an_embolic_protection_device.html.
89. Minutello R.M., Bhagan S., Sharma A., Slotwiner A.J., Feldman D.N., Cuomo L.J., et al. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease. J Interv Cardiol 2007, 20:458-465.
90. Mishra A., Sirasena T., Slaughter R., Pohlner P., Walters D.L. Percutaneous treatment of an occlusive left main pseudoaneurysm: a role for multimodality imaging. Cardiovasc Revasc Med 2010.
91. Moltzer E., Roos-Hesselink J.W., Yap S.C., Cuypers J.A., Bogers A.J., de Jaegere P.P., et al. Endovascular stenting for aortic (re)coarctation in adults. Neth Heart J 2010, 18:430-436.
92. Muller-Hulsbeck S., Walluscheck K.P., Priebe M., Grimm J., Cremer J., Heller M. Experience on endothelial cell adhesion on vascular stents and stent-grafts: first in vitro results. Invest Radiol 2002, 37:314-320.
93. Muni N.I., Gross T.P. Problems with drug-eluting coronary stents-the FDA perspective. N Engl J Med 2004, 351:1593-1595.
94. Murphy B.P., Gilbert T. Case report: coronary steal secondary to a left main coronary artery-pulmonary artery fistula only manifest after coronary artery bypass surgery. Int J Cardiol 2009, 137:e47-e48.
95. Mylonas I., Sakata Y., Salinger M.H., Feldman T. Successful closure of a giant true saphenous vein graft aneurysm using the Amplatzer vascular plug. Catheter Cardiovasc Interv 2006, 67:611-616.
96. Nagai N., Kubota R., Okahashi R., Munekata M. Blood compatibility evaluation of elastic gelatin gel from salmon collagen. J Biosci Bioeng 2008, 106:412-415.
97. Nagai N., Nakayama Y., Zhou Y.M., Takamizawa K., Mori K., Munekata M. Development of salmon collagen vascular graft: mechanical and biological properties and preliminary implantation study. J Biomed Mater Res B Appl Biomater 2008, 87:432-439.
98. Nagai N., Nakayama Y., Nishi S., Munekata M. Development of novel covered stents using salmon collagen. J Artif Organs 2009, 12:61-66.
99. Nakano K., Egashira K., Masuda S., Funakoshi K., Zhao G., Kimura S., et al. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. JACC Cardiovasc Interv 2009, 2:277-283.
100. Nakayama Y., Nishi S., Ishibashi-Ueda H., Matsuda T. Surface microarchitectural design in biomedical applications: in vivo analysis of tissue ingrowth in excimer laser-directed micropored scaffold for cardiovascular tissue engineering. J Biomed Mater Res 2000, 51:520-528.
101. Nakayama Y., Nishi S., Ishibashi-Ueda H. Fabrication of drug-eluting covered stents with micropores and differential coating of heparin and FK506. Cardiovasc Radiat Med 2003, 4:77-82.
102. Nakayama Y., Nishi S., Ishibashi-Ueda H., Okamoto Y., Nemoto Y. Development of microporous covered stents: geometrical design of the luminal surface. Int J Artif Organs 2005, 28:600-608.
103. Nakayama Y., Zhou Y.M., Ishibashi-Ueda H. Development of in vivo tissue-engineered autologous tissue-covered stents (biocovered stents). J Artif Organs 2007, 10:171-176.
104. Nie S.P., Qiao Y., Wan D.G., Jian L.G., Ma C.S. Polytetrafluoroethylene-covered stent implantation with double guiding catheter technique for the treatment of type III coronary perforation after stenting. Chin Med J (Engl) 2010, 123:2741-2743.
105. Nishi S., Nakayama Y., Ishibashi-Ueda H., Okamoto Y., Kinoshita Y. High-performance self-expanding stent graft: development and application to experimental aneurysms. J Artif Organs 2009, 12:35-39.
106. NuMED NuMED Cheatham-platinum stent [Ref Type: Electronic Citation]. http://www.numedforchildren.com/cpstent-ce.htm.
107. Nuttelman C.R., Mortisen D.J., Henry S.M., Anseth K.S. Attachment of fibronectin to poly(vinyl alcohol) hydrogels promotes NIH3T3 cell adhesion, proliferation, and migration. J Biomed Mater Res 2001, 57:217-223.
108. Okner R., Oron M., Tal N., Nyska A., Kumar N., Mandler D., et al. Electrocoating of stainless steel coronary stents for extended release of paclitaxel. J Biomed Mater Res A 2009, 88:427-436.
109. Orlic D., Vitrella G., Corvaja N., Colombo A. New technique to seal a long giant coronary aneurysm with PTFE-covered stents: a case report. Catheter Cardiovasc Interv 2006, 67:41-45.
110. Ozlu M.F., Ozcan F., Maden O., Dogan F.M., Cagli K. Simultaneous treatment of a fistula and a stenosis at right coronary artery: one stone two birds. Int J Cardiol 2009, 149:118-119.
111. Panetta C.J., Schneider W., Boller M.A. Percutaneous management of a long saphenous vein graft aneurysm: a case report and review of literature. Cardiol Res Pract 2009, 2009:981292.
112. Pant S., Bressloff N.W., Limbert G. Geometry parameterization and multidisciplinary constrained optimization of coronary stents. Biomech Model Mechanobiol 2011, 11:61-82.
113. Pedra C.A., Fontes V.F., Esteves C.A., Pilla C.B., Braga S.L., Pedra S.R., et al. Stenting vs. balloon angioplasty for discrete unoperated coarctation of the aorta in adolescents and adults. Catheter Cardiovasc Interv 2005, 64:495-506.
114. Pedra C.A., Fontes V.F., Esteves C.A., Arrieta S.R., Braga S.L., Justino H., et al. Use of covered stents in the management of coarctation of the aorta. Pediatr Cardiol 2005, 26:431-439.
115. PFM Medical PFM medical covered CP stent instructions for use [Ref Type: Electronic Citation]. http://www.pfmmedical.com/fileadmin/redaktion/produktkatalog/interventionelle_stentsysteme/kardiologische_stents/06_Dokumente/IFU%20Covered%20CP%20Stent.pdf.
116. Pieniazek P., Dzierwa K., Musialek P., Hlawaty M., Tekieli L., Paluszek P., et al. The use of a novel type of distal protection system (FiberNet(R)) in the percutaneous management of saphenous vein graft disease. Kardiol Pol 2010, 68:1423-1425.
117. Qureshi S.A. Use of covered stents to treat coarctation of the aorta. Korean Circ J 2009, 39:261-263.
118. Radosevich M., Goubran H.I., Burnouf T. Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. Vox Sang 1997, 72:133-143.
119. Rahmani B., Tzamtzis S., Ghanbari H., Burriesci G., Seifalian A.M. Manufacturing and hydrodynamic assessment of a novel aortic valve made of a new nanocomposite polymer. J Biomech 2012, 45:1205-1211.
120. Ramana R.K., Arab D., Joyal D., Steen L., Cho L., Lewis B., et al. Coronary artery perforation during percutaneous coronary intervention: incidence and outcomes in the new interventional era. J Invasive Cardiol 2005, 17:603-605.
121. Ramana R.K., Ronan A., Cohoon K., Homan D., Sutherland J., Steen L., et al. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease. Catheter Cardiovasc Interv 2008, 71:886-893.
122. Ratto G.B., Spinelli E., Lunghi C., Tomellini M., Sacco A., Motta G. Morphological evaluation of the human umbilical vein graft. An experimental study. Eur Surg Res 1983, 15:151-160.
123. Richard R.E., Schwarz M., Ranade S., Chan A.K., Matyjaszewski K., Sumerlin B. Evaluation of acrylate-based block copolymers prepared by atom transfer radical polymerization as matrices for paclitaxel delivery from coronary stents. Biomacromolecules 2005, 6:3410-3418.
124. Rogers J.H., Laird J.R. Overview of new technologies for lower extremity revascularization. Circulation 2007, 116:2072-2085.
125. Romaguera R., Gomez-Hospital J.A., Cequier A. Novel use of the Mguard mesh-covered stent to treat coronary arterial perforations. Catheter Cardiovasc Interv 2012, 80:75-78.
126. Sanchez-Recalde A., Jimenez V.S., Moreno R., Barreales L., Lozano I., Galeote G., et al. Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis. EuroIntervention 2010, 6:149-160.
127. Sarkar S., Salacinski H.J., Hamilton G., Seifalian A.M. The mechanical properties of infrainguinal vascular bypass grafts: their role in influencing patency. Eur J Vasc Endovasc Surg 2006, 31:627-636.
128. Satler L.F., Mintz G. Promises, promises: the covered stent. Catheter Cardiovasc Interv 2000, 50:89.
129. Satler L.F., Muntz G. The promise of the covered stent. Catheter Cardiovasc Interv 1999, 46:466.
130. Sato S., Nakayama Y., Miura Y., Okamoto Y., Asano H., Ishibashi-Ueda H., et al. Development of self-expandable covered stents. J Biomed Mater Res B Appl Biomater 2007, 83:345-353.
131. Sato S., Nakayama Y., Matsuhashi T., Seiji K., Matsunaga K., Takasawa C., et al. Evaluation of self-expandable, FK506-coated, covered stents in canine animal model. J Biomed Mater Res B Appl Biomater 2009, 90:647-652.
132. Schachinger V., Hamm C.W., Munzel T., Haude M., Baldus S., Grube E., et al. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol 2003, 42:1360-1369.
133. Schurmann K., Lahann J., Niggemann P., Klosterhalfen B., Meyer J., Kulisch A., et al. Biologic response to polymer-coated stents: in vitro analysis and results in an iliac artery sheep model. Radiology 2004, 230:151-162.
134. Schwartz R.S., Huber K.C., Murphy J.G., Edwards W.D., Camrud A.R., Vlietstra R.E., et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992, 19:267-274.
135. Sefton M.V., Gemmell C.H., Gorbet M.B. What really is blood compatibility?. J Biomater Sci Polym Ed 2000, 11:1165-1182.
136. Shanmugasundaram S., Griswold K.A., Prestigiacomo C.J., Arinzeh T., Jaffe M. Applications of electrospinning: tissue engineering scaffolds and drug delivery system. Bioengineering 2004, 140-141. [Ref Type: Conference Proceeding].
137. Shaulov Y., Okner R., Levi Y., Tal N., Gutkin V., Mandler D., et al. Poly(methyl methacrylate) grafting onto stainless steel surfaces: application to drug-eluting stents. ACS Appl Mater Interfaces 2009, 1:2519-2528.
138. Shirakabe A., Takano H., Nakamura S., Kikuchi A., Sasaki A., Yamamoto E., et al. Coronary perforation during percutaneous coronary intervention. Int Heart J 2007, 48:1-9.
139. Shirota T., Yasui H., Shimokawa H., Matsuda T. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 2003, 24:2295-2302.
140. Shishehbor M.H., Hawi R., Singh I.M., Tuzcu E.M., Bhatt D.L., Ellis S.G., et al. Drug-eluting versus bare-metal stents for treating saphenous vein grafts. Am Heart J 2009, 158:637-643.
141. Shuchman M. Trading restenosis for thrombosis? New questions about drug-eluting stents. N Engl J Med 2006, 355:1949-1952.
142. Sigwart U., Puel J., Mirkovitch V., Joffre F., Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987, 316:701-706.
143. Silver F.H., Horvath I., Foran D.J. Viscoelasticity of the vessel wall: the role of collagen and elastic fibers. Crit Rev Biomed Eng 2001, 29:279-301.
144. Singla A.K., Chawla M. Chitosan: some pharmaceutical and biological aspects-an update. J Pharm Pharmacol 2001, 53:1047-1067.
145. Stankovic G., Colombo A., Presbitero P., van den Branden F., Inglese L., Cernigliaro C., et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial. Circulation 2003, 108:37-42.
146. Stefanadis C., Toutouzas K., Tsiamis E., Vlachopoulos C., Vaina S., Tsekoura D., et al. Stents covered by an autologous arterial graft in porcine coronary arteries: feasibility, vascular injury and effect on neointimal hyperplasia. Cardiovasc Res 1999, 41:433-442.
147. Stefanadis C., Toutouzas K., Tsiamis E., Vlachopoulos C., Kallikazaros I., Stratos C., et al. Stents covered by autologous venous grafts: feasibility and immediate and long-term results. Am Heart J 2000, 139:437-445.
148. Stefanadis C., Toutouzas K., Tsiamis E., Toutouzas P. Covered stents by autologous vascular grafts: effect of radiation and external heating of stents. J Invasive Cardiol 2001, 13:143-147.
149. Stefanadis C., Toutouzas K., Tsiamis E., Toutouzas P. New stent design for autologous venous graft-covered stent preparation: first human application for sealing of a coronary aneurysm. Catheter Cardiovasc Interv 2002, 55:222-227.
150. Steffel J., Eberli F.R., Luscher T.F., Tanner F.C. Drug-eluting stents - what should be improved?. Ann Med 2008, 40:242-252.
151. Stenzel K.H., Miyata T., Rubin A.L. Collagen as a biomaterial. Annu Rev Biophys Bioeng 1974, 3:231-253.
152. Stone G.W., Goldberg S., O'Shaughnessy C., Midei M., Siegel R.M., Cristea E., et al. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts: the randomized BARRICADE (Barrier Approach to Restenosis: Restrict Intima to Curtail Adverse Events) trial. JACC Cardiovasc Interv 2011, 4:300-309.
153. Sydow-Plum G., Tabrizian M. Review of stent coating strategies: clinical insights. Mater Sci Technol 2008, 24:1127-1143.
154. Sydow-Plum G., Haidar Z.S., Merhi Y., Tabrizian M. Modulating the release kinetics of paclitaxel from membrane-covered stents using different loading strategies. Materials 2008, 1:25-43.
155. Szalat A., Durst R., Cohen A., Lotan C. Use of polytetrafluoroethylene-covered stent for treatment of coronary artery aneurysm. Catheter Cardiovasc Interv 2005, 66:203-208.
156. Takano M., Yamamoto M., Inami S., Xie Y., Murakami D., Okamatsu K., et al. Delayed endothelialization after polytetrafluoroethylene-covered stent implantation for coronary aneurysm. Circ J 2009, 73:190-193.
157. Tan H.Q., Li M.H., Zhang P.L., Li Y.D., Wang J.B., Zhu Y.Q., et al. Reconstructive endovascular treatment of intracranial aneurysms with the Willis covered stent: medium-term clinical and angiographic follow-up. J Neurosurg 2010, 114:1014-1020.
158. Tanous D., Benson L.N., Horlick E.M. Coarctation of the aorta: evaluation and management. Curr Opin Cardiol 2009, 24:509-515.
159. Tanous D., Collins N., Dehghani P., Benson L.N., Horlick E.M. Covered stents in the management of coarctation of the aorta in the adult: initial results and 1-year angiographic and hemodynamic follow-up. Int J Cardiol 2010, 140:287-295.
160. Teirstein P.S. Drug-eluting stent restenosis: an uncommon yet pervasive problem. Circulation 2010, 122:5-7.
161. Teis-Soley A., Fernandez-Nofrerias E., Rodriguez-Leor O., Tizon H., Salvatella N., Valle V., et al. Coronary artery perforation by intracoronary guide wires: risk factors and clinical outcomes. Rev Esp Cardiol 2010, 63:730-734.
162. Thierry B., Merhi Y., Silver J., Tabrizian M. Biodegradable membrane-covered stent from chitosan-based polymers. J Biomed Mater Res A 2005, 75:556-566.
163. Tiewei Q., Ali A., Shaolei G., Feng L., Zhongsong S., Xuesong L., et al. Carotid cavernous fistulas treated by endovascular covered stent grafts with follow-up results. Br J Neurosurg 2010, 24:435-440.
164. Turco M.A., Buchbinder M., Popma J.J., Weissman N.J., Mann T., Doucet S., et al. Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial. Catheter Cardiovasc Interv 2006, 68:379-388.
165. Tzifa A., Ewert P., Brzezinska-Rajszys G., Peters B., Zubrzycka M., Rosenthal E., et al. Covered Cheatham-platinum stents for aortic coarctation: early and intermediate-term results. J Am Coll Cardiol 2006, 47:1457-1463.
166. Venkatraman S., Boey F., Lao L.L. Implanted cardiovascular polymers: natural, synthetic and bio-inspired. Prog Polym Sci 2008, 33(9):853-874.
167. Waltham M., Harris J. Intimal hyperplasia: the nemesis of cardiovascular intervention. ANZ J Surg 2004, 74:719-720.
168. Wang C., Xie X., You C., Zhang C., Cheng M., He M., et al. Placement of covered stents for the treatment of direct carotid cavernous fistulas. AJNR Am J Neuroradiol 2009, 30:1342-1346.
169. Wang G.X., Luo L.L., Yin T.Y., Li Y., Jiang T., Ruan C.G., et al. Ultrasonic atomization and subsequent desolvation for monoclonal antibody (mAb) to the glycoprotein (GP) IIIa receptor into drug eluting stent. J Microencapsul 2010, 27:105-114.
170. Weaver J.D., Ku D.N. Mechanical evaluation of polyvinyl alcohol cryogels for covered stents. Med Devices 2010, 4.
171. Weaver J.D., Ku D.N. Biomaterial testing for covered stent membranes: evaluating thrombosis and restenosis potential. J Biomed Mater Res B Appl Biomater 2011, 100:103-110.
172. Weisel J.W. The mechanical properties of fibrin for basic scientists and clinicians. Biophys Chem 2004, 112:267-276.
173. Wendel H.P., Avci-Adali M., Ziemer G. Endothelial progenitor cell capture stents-hype or hope?. Int J Cardiol 2010, 145:115-117.
174. Wu X., Wang G., Tang C., Zhang D., Li Z., Du D., et al. Mesenchymal stem cell seeding promotes reendothelialization of the endovascular stent. J Biomed Mater Res A 2011, 98:442-449.
175. Yi A.C., Palmer E., Luh G.Y., Jacobson J.P., Smith D.C. Endovascular treatment of carotid and vertebral pseudoaneurysms with covered stents. AJNR Am J Neuroradiol 2008, 29:983-987.
176. Yu D.G., Zhu L.M., White K., Bradford-White C. Electrospun nanofiber-based drug delivery systems. Med Healthc 2009, 67-75.
177. Zahn R., Jessl J., Achenbach S., Ropers D., Schwab J., Daniel W.G. Treatment of a large coronary saphenous bypass graft aneurysm by implantation of covered stents. Clin Res Cardiol 2006, 95:313-315.
178. Zhang M., Kang W.C., Moon C.I., Han S.H., Ahn T.H., Shin E.K. Coronary artery perforation following implantation of a drug-eluting stent rescued by deployment of a covered stent in symptomatic myocardial bridging. Korean Circ J 2010, 40:148-151.